Relaxin in Endometriosis

article OA: closed CC0 ⤵ 3 in-corpus citations
View on OpenAlex View on PubMed View at publisher
AI-generated summary by claude@2026-06, 2026-06-08

This study compared relaxin and its receptor mRNA expression in normal endometrium versus endometriosis samples to investigate relaxin's potential role in the disease.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

Endometriosis is an important contributing factor to chronic pelvic pain and infertility. Matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) have each been implicated in the establishment of endometriotic lesions. Since relaxin regulates the expression of MMPs and VEGF in the endometrium, we tested the hypothesis that relaxin plays a role in endometriosis by comparing the expression of relaxin mRNA and its LGR7 (RXFP1) receptor mRNA in normal human endometrium to those in samples from patients with endometriosis.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_paininfertility

MeSH descriptors

Endometriosis Relaxin Endometriosis Female Gene Expression Profiling Gene Expression Regulation Humans Menstrual Cycle Menstrual Cycle Receptors, G-Protein-Coupled Receptors, G-Protein-Coupled Receptors, Peptide Receptors, Peptide Relaxin Reverse Transcriptase Polymerase Chain Reaction RNA, Messenger RNA, Messenger

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cites (4)

Cited by (3)

References (6)

Cited by (3)

Source provenance

europepmc
last seen: 2026-06-18T06:15:08.409253+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:14:05.573375+00:00
unpaywall
last seen: 2026-06-18T06:36:33.011116+00:00
License: CC0 · commercial use OK